Compound amoxicillin powder and preparation method thereof
By adjusting the component ratio and adding anhydrous citric acid, magnesium sulfate, etc. in the compound amoxicillin powder, water solubility and storage stability are improved, and the existing compound amoxicillin powder has poor water solubility and easy discoloration are solved, and the problem of existing compound amoxicillin powder is achieved. Long-term storage and efficient dissolution effect.
Patent Information
- Application Number
- CN202411024138.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-22
AI Technical Summary
The existing veterinary compound amoxicillin powder has insufficient water solubility and storage stability, resulting in poor drinking water administration and easy discoloration, affecting the use effect.
Using a compound powder with a mass ratio of amoxicillin and potassium clavulanate of 4:1, add anhydrous citric acid, anhydrous magnesium sulfate and disodium ethylenediaminetetraacetic acid, and react with citric acid and sodium bicarbonate. The formation of sodium citrate provides pH buffering, enhances aqueous solution stability, and reduces the influence of metal ions through the complexation of magnesium sulfate and disodium ethylenediaminetetraacetate.
It significantly improves the water solubility and storage stability of compound amoxicillin powder. The aqueous solution remains stable for more than 95% within 24 hours, and can be stored for 6 months without changing color under high temperature and high humidity conditions. It is stored for 24 months under normal storage conditions. No change.
Smart Images

Figure CN118986894A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of veterinary drugs, and particularly relates to a compound amoxicillin powder and a preparation method thereof. Background Art
[0002] Amoxicillin (also known as amoxicillin) is a common antibacterial drug that was used clinically in the 1970s. It effectively kills bacteria by inhibiting the synthesis of bacterial cell walls. It has strong acid resistance and is a broad-spectrum antibacterial drug. At present, the proportion of bacteria that can produce β-lactamase in clinical practice is increasing, and amoxicillin will be decomposed and ineffective by β-lactamase, which seriously affects its efficacy. To solve this problem, a company has developed a compound preparation of amoxicillin and potassium clavulanate. Clavulanic acid is produced by fermentation of Streptomyces rod-shaped. Although it has no obvious antibacterial activity itself, it can inhibit the activity of β-lactamase and protect amoxicillin from hydrolysis by β-lactamase, thereby enhancing its antibacterial effect, greatly broadening its antibacterial spectrum, and also reducing bacterial resistance.
[0003] As a veterinary drug, amoxicillin is currently usually delivered into the animal body by drinking water to achieve the purpose of treatment. However, the solubility of amoxicillin in water is not high. For ranches or farms using automatic drinking water lines, the drug may not be completely dissolved in water, which may cause the drinking water line to be blocked. Moreover, the stability of amoxicillin in water is easily affected by factors such as acid and alkali. Drinking water administration is the most commonly used drug administration method in modern large-scale farming. If the drug has poor stability and easy degradation in aqueous solution, it will directly affect the use effect. Potassium clavulanate has good water solubility, but because its raw material drug itself has strong hygroscopicity, it is unstable under high temperature and high humidity conditions and is very easy to degrade and discolor. At present, the quality of veterinary compound amoxicillin powder on the market is uneven, and because clavulanic acid is easy to degrade and discolor, although researchers are trying to improve the water solubility and storage stability of compound amoxicillin powder by adding stabilizers, cosolvents, etc., a compound amoxicillin powder with satisfactory effect has not yet been obtained. Summary of the invention
[0004] In view of this, the present invention provides a compound amoxicillin powder and a preparation method thereof. The compound amoxicillin powder provided by the present invention not only has excellent water solubility, but also has good aqueous solution stability and storage stability, wherein the aqueous solution can be stably present for at least 24 hours, and the powder product can be stably stored for 24 months under normal conditions, greatly extending the shelf life.
[0005] To solve the above technical problems, the first aspect of the present invention provides a compound amoxicillin powder, which comprises the following components, measured by mass percentage: 12.0% to 18.0% of amoxicillin-clavulanate potassium mixed powder, 1.0% to 3.0% of anhydrous magnesium sulfate, 0.5% to 1.5% of sodium bicarbonate, 0.5% to 1.5% of anhydrous citric acid, 0.2% to 0.4% of disodium edetate, and the balance is sodium chloride. The mass ratio of amoxicillin to potassium clavulanate in the amoxicillin-clavulanate potassium mixed powder is 4:1.
[0006] The compound amoxicillin powder provided by the present invention is mainly composed of a mixed powder with a mass ratio of amoxicillin to potassium clavulanate of 4:1, and creatively adds anhydrous citric acid accounting for 0.5% to 1.5% by mass. The addition of anhydrous citric acid not only does not reduce the water solubility of amoxicillin, but also greatly improves the stability of the aqueous solution of the compound amoxicillin powder. The inventor speculates that one of the reasons may be that citric acid and sodium bicarbonate react in water to form sodium citrate (anhydrous citric acid is in excess relative to sodium bicarbonate in this formula). Sodium citrate, as a weak acid and strong base salt, can form a stronger pH buffer with excess citric acid, providing a more stable pH environment for the aqueous solution of the compound amoxicillin powder, thereby providing a guarantee for the stable existence of amoxicillin and potassium clavulanate without degradation; secondly, the generated sodium citrate is effective for Ca that may exist in the preparation water. 2+ Mg 2+ and the Fe content in the metal container used for preparation 3+ and Fe 2+ The metal ions have good complexing ability, which can also improve the stability of its aqueous solution; secondly, the excessive presence of citric acid has a certain antioxidant effect because it contains hydroxyl groups that are easily reduced, which prolongs the storage stability of the compound amoxicillin powder.
[0007] In addition, the present invention also uses an appropriate amount of magnesium sulfate as an anti-caking agent to prevent the product from agglomerating due to moisture absorption, thereby affecting the solubility and efficacy of the product; and uses disodium ethylenediaminetetraacetic acid as a complexing agent to remove metal ions in the solution, thereby reducing the influence of the metal ions on the main components.
[0008] The dosage of magnesium sulfate in the present invention can both minimize the influence of moisture on clavulanic acid (because clavulanic acid is easy to absorb moisture and decompose), and prevent diarrhea in the user due to excessive dosage.
[0009] In combination with the first aspect, the compound amoxicillin powder provided by the present invention comprises the following components in terms of mass percentage: 12.0% to 15.0% of amoxicillin clavulanate potassium mixed powder, 2.0% to 3.0% of anhydrous magnesium sulfate, 1.0% to 1.5% of sodium bicarbonate, 1.0% to 1.5% of anhydrous citric acid, 0.3% to 0.4% of disodium edetate, and the balance is sodium chloride.
[0010] Preferably, the compound amoxicillin powder provided by the present invention comprises, by mass percentage, 12.5% of amoxicillin clavulanate potassium mixed powder, 3.0% of anhydrous magnesium sulfate, 1.5% of sodium bicarbonate, 1.5% of anhydrous citric acid, 0.4% of disodium edetate, and the balance is sodium chloride.
[0011] In combination with the first aspect, the added mass ratio of the sodium bicarbonate and the anhydrous citric acid is 1:1.
[0012] In combination with the first aspect, the particle sizes of the anhydrous magnesium sulfate, anhydrous citric acid, sodium bicarbonate and disodium edetate are all less than 200 μm, preferably not more than 180 μm.
[0013] In combination with the first aspect, the particle size of the sodium chloride is less than or equal to 150 μm.
[0014] The excipients in the above-mentioned particle size range can be mixed more evenly with the active ingredients amoxicillin and potassium clavulanate, thereby avoiding stratification or agglomeration of the main drug and the excipients during the subsequent transportation of the product, thereby ensuring that the compound amoxicillin powder has both good water solubility and higher storage stability.
[0015] In combination with the first aspect, when the compound amoxicillin powder is prepared into a 10 g / L aqueous solution, the pH value is 5.3-5.5.
[0016] The second aspect of the present invention provides a production process of the above-mentioned compound amoxicillin powder, the steps of which are to sieve each raw material and auxiliary material, weigh the raw material and auxiliary material in the prescribed amount, place them in a mixer, mix them evenly, and package them.
[0017] The production process of the compound amoxicillin powder provided by the invention is simple, and the required raw and auxiliary materials only need to be sieved and then placed in a mixer for mixing, without the need for step-by-step addition, thereby greatly simplifying the production process and improving production efficiency.
[0018] In combination with the second aspect, in the production process of the compound amoxicillin powder, the production environment temperature is controlled below 25° C. and the humidity is controlled below 40% RH. Such temperature and humidity conditions can ensure that the prepared compound amoxicillin powder has better storage stability.
[0019] The solubility of the compound amoxicillin powder provided by the present invention in water at 25°C can reach 15g / L. At 24h after being dissolved in water, the content of amoxicillin and clavulanic acid in the aqueous solution can still be stably maintained at more than 95%, indicating that the aqueous solution has good stability within 24h. Moreover, the compound amoxicillin powder provided by the present invention can still be stably stored for at least 6 months without discoloration under the high temperature and high humidity conditions of the accelerated experiment, and the powder still does not change color after being stored for 24 months under normal storage conditions, and the content of clavulanic acid and amoxicillin is still maintained at more than 99%, and the moisture content is less than 1.70%, indicating that it has good storage stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 , (a) is a sample photograph of commercial product 1 after accelerated stability test, (b) is a sample photograph of the product of Example 1 after accelerated stability test, (c) is a sample photograph of the product of Example 2 after accelerated stability test, and (d) is a sample photograph of the product of Example 3 after accelerated stability test. DETAILED DESCRIPTION
[0021] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0022] Amoxicillin has good water solubility in alkaline environment, so its water solubility is often improved by adding weak base salts, but amoxicillin and clavulanic acid will degrade under alkaline conditions, and the current compound amoxicillin powder still has problems such as poor water solubility, easy discoloration and short shelf life. In view of this, the present invention provides a compound amoxicillin powder, which has better water solubility and aqueous solution stability, is more conducive to long-term storage, is not easy to discolor, and can still meet the veterinary drug quality standards after being stored for 2 years.
[0023] The preparation methods in the following examples and comparative examples are:
[0024] The weighed raw materials and auxiliary materials are placed in a mixer, mixed evenly, and then packaged to obtain the finished compound amoxicillin powder. In the following examples and comparative examples, the particle size of the sodium chloride used is ≤150 μm, and the particle sizes of anhydrous magnesium sulfate, anhydrous citric acid, sodium bicarbonate, and disodium edetate are all less than 180 μm.
[0025] Embodiments 1 to 5
[0026] Examples 1 to 5 respectively provide a compound amoxicillin powder, and the specific formula compositions thereof are shown in Table 1.
[0027] Comparative Examples 1 to 8
[0028] Comparative Examples 1 to 8 respectively provide a compound amoxicillin powder having a different formula or composition from the compound amoxicillin powder in the embodiment, and the specific formula composition is shown in Table 1.
[0029] Table 1
[0030]
[0031] In order to verify the stability and water solubility of the compound amoxicillin powder provided by the present invention, the inventors conducted solubility experiments and stability experiments (including stability experiments in simulated gastric acid solution with a pH of 3.0, accelerated stability experiments, and long-term stability experiments) on the compound amoxicillin powder obtained in Experimental Examples 1 to 5.
[0032] Test Example 1
[0033] This test example tests the maximum solubility of the compound amoxicillin powder obtained in Examples 1 to 5 in tap water and the stability after dissolution, and the steps are as follows:
[0034] (1) Maximum solubility determination
[0035] Weigh appropriate amounts of the compound amoxicillin powder samples obtained in Examples 1 to 5 and Comparative Examples 1 to 8 respectively and record the weights, add them to an equal volume of prepared tap water (preheated to 25° C.) while stirring, and stop adding when granular insoluble matter or insoluble suspended matter appears. Calculate the amount added and dissolved in water by weighing the remaining amount of each sample, and calculate the maximum solubility (sample addition amount / tap water volume).
[0036] (2) Stability test of the solution with the highest solubility concentration
[0037] According to the highest solubility measured in step (1), a solution with the highest solubility concentration is prepared, sealed, placed in a 25°C water bath, and samples are taken for Examples 1 to 5 at 0h, 4h, 8h, 12h, 18h and 24h, and samples are taken for Comparative Examples 1 to 8 at 0h and 24h, and purified water is added to dilute to prepare a 0.2mg / mL (in terms of amoxicillin) solution, filtered, and the subsequent filtrate is taken. The content of amoxicillin and clavulanic acid in the solution with the highest solubility concentration at different time points is determined according to the chromatographic conditions of the determination of the content of compound amoxicillin powder in the "Quality Standards for Veterinary Drugs" (2017 Edition of Chemical Drugs Volume). At the same time, the highest solubility of commercial products 1 and commercial products 2 in tap water and the stability of the solution with the highest solubility concentration are determined by the same method, and the results are shown in Table 2.
[0038] Table 2
[0039]
[0040]
[0041] As can be seen from Table 2, the maximum solubility of the compound amoxicillin powder provided by Examples 1 to 5 of the present invention in tap water is stably higher than that of the commercially available product, and the stability of amoxicillin and clavulanic acid in tap water within 24 hours is significantly better than that of the commercially available product and the comparative example, indicating that the simultaneous addition of sodium bicarbonate and anhydrous citric acid can significantly improve the solubility of the compound amoxicillin powder in water and is beneficial to the stability of the product aqueous solution.
[0042] Test Example 2
[0043] This test example tests the stability of the compound amoxicillin powder obtained in Examples 1 to 4 and Comparative Examples 1 to 2 in a simulated gastric acid solution with a pH of 3.0, and the steps are as follows:
[0044] (1) Preparation of artificial chicken gastric acid
[0045] Take an appropriate amount of purified water (sample quantity * 1050mL), preheat it to 37℃ in a water bath, add dilute hydrochloric acid solution to adjust the pH to 3.0, seal, continue preheating, and use it after the temperature stabilizes at 37℃.
[0046] (2) Stability test in simulated gastric acid solution with a pH of 3.0
[0047] According to the results of the highest solubility determination in Test Example 1, solutions with the highest solubility concentration were prepared respectively (the samples to be tested in each embodiment were weighed appropriately, accurately weighed, and placed in a 1000mL volumetric flask), dissolved and diluted to the scale with artificial chicken gastric acid at pH 3.0, shaken, sealed, placed in a 37°C water bath, accurately measured appropriately at 0h, 0.5h, 1h, and 2h, diluted to 0.2mg / mL (in terms of amoxicillin) with purified water, and assayed according to the chromatographic conditions under the compound amoxicillin powder item of the Veterinary Drug Quality Standard (2017 Edition Chemical Drug Volume). At the same time, the stability of commercially available products 1 and commercially available products 2 in a gastric acid solution with a pH of 3.0 was determined by the same method, and the test results are shown in Table 3.
[0048] Table 3
[0049]
[0050] As can be seen from Table 3, the stability of amoxicillin and clavulanic acid in the compound amoxicillin powder provided by Examples 1 to 4 of the present invention in a simulated chicken gastric acid solution with a pH of 3.0 within 2 hours is significantly better than that of the commercially available product and Comparative Examples 1 to 2.
[0051] Test Example 3
[0052] In this test example, the compound amoxicillin powder obtained in Examples 1 to 4 and Comparative Examples 1 to 2 is subjected to an accelerated stability test, and the steps are as follows: the compound amoxicillin powder obtained in Examples 1 to 4 and Comparative Examples 1 to 2 and the commercially available product 1 and the commercially available product 2 are placed at a temperature of 40°C and a humidity of 75%RH for 6 months, and samples are taken at the 1st, 2nd, 3rd and 6th months, respectively, and the properties, moisture content and amoxicillin and clavulanic acid content of each sample are investigated and determined (according to the chromatographic conditions under the compound amoxicillin powder item of the Quality Standards for Veterinary Drugs (2017 Edition of Chemical Drugs Volume)). The results are shown in Table 4, and the photos of the samples after the accelerated stability test are shown in Table 4. Figure 1 shown.
[0053] Table 4
[0054] .
[0056] As can be seen from Table 4, compared with the commercial product, the compound amoxicillin powder provided in Examples 1 to 4 of the present invention has almost no color change under accelerated conditions, and the stability of amoxicillin is equivalent to that of the commercial product, but the stability of clavulanic acid is significantly better than that of the commercial product. As can be seen from Comparative Examples 1 to 2, when the amount of magnesium sulfate added exceeds the addition range specified in the present invention or anhydrous citric acid is replaced with sodium citrate used in the prior art, the moisture content of the compound amoxicillin powder obtained in Comparative Examples 1 to 2 during storage is significantly increased compared with the examples, and at the same time, the storage stability of amoxicillin and clavulanic acid is also significantly reduced.
[0057] Test Example 4
[0058] In this test example, a long-term stability test was conducted on the compound amoxicillin powder obtained in Examples 1 to 3, and the steps were as follows: the compound amoxicillin powder obtained in Examples 1 to 3 was placed at a temperature of 25°C and a humidity of 60% RH for 24 months, and samples were taken at the 3rd, 6th, 9th, 12th, 18th and 24th months, and the properties, moisture content and amoxicillin and clavulanic acid content of each sample were investigated and determined (according to the chromatographic conditions under the compound amoxicillin powder item of the Quality Standards for Veterinary Drugs (2017 Edition of Chemical Drugs Volume)). The results are shown in Table 5.
[0059] Table 5
[0060]
[0061]
[0062] It can be seen from Table 5 that the compound amoxicillin powder provided by Examples 1 to 3 of the present invention has almost no color change under long-term test conditions, and the stability of amoxicillin and clavulanic acid is good. Within 24 months, all indicators are within the limits specified in the veterinary drug quality standards, and the product does not clump.
[0063] Test Example 5
[0064] The inventors also measured the pH of the compound amoxicillin powder obtained in Examples 1 to 4 and Comparative Examples 1 to 7 at the same solution concentration (1 g of the product was weighed and dissolved in 100 mL of 25° C. purified water). The results are shown in Table 6.
[0065] Table 6
[0066]
[0067] It can be seen from Table 6 that the pH range of the aqueous solution (10 g / L) of the compound amoxicillin powder provided by the present invention is 5.3-5.5, and it can be seen from Comparative Examples 2-7 that when anhydrous citric acid is not used in combination with sodium bicarbonate or even if it is used in combination but the addition amount exceeds the addition range specified in the present invention, the pH of the 10 g / L aqueous solution of the obtained product will exceed the pH range of the aqueous solution of the same concentration of the product provided in the embodiment of the present invention, further illustrating that the composition and addition amount of the formula in the present invention cannot be changed at will.
[0068] What is described above is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A compound amoxicillin powder, characterized in that: Calculated by mass percentage, the composition comprises the following components: 12.0% to 18.0% amoxicillin and clavulanate potassium mixed powder, 1.0% to 3.0% anhydrous magnesium sulfate, 0.5% to 1.5% sodium bicarbonate, 0.5% to 1.5% anhydrous citric acid, 0.2% to 0.4% disodium ethylenediaminetetraacetate, and the balance is sodium chloride. The mass ratio of amoxicillin to clavulanate potassium in the amoxicillin and clavulanate potassium mixed powder is 4:
1.
2. The compound amoxicillin powder according to claim 1, characterized in that: Calculated by mass percentage, the composition includes: 12.0% to 15.0% of amoxicillin and clavulanate potassium mixed powder, 2.0% to 3.0% of anhydrous magnesium sulfate, 1.0% to 1.5% of sodium bicarbonate, 1.0% to 1.5% of anhydrous citric acid, 0.3% to 0.4% of disodium ethylenediaminetetraacetate, and the balance is sodium chloride.
3. The compound amoxicillin powder according to claim 1 or 2, characterized in that: Calculated by mass percentage, the mixed powder consists of 12.5% amoxicillin and clavulanate potassium, 3.0% anhydrous magnesium sulfate, 1.5% sodium bicarbonate, 1.5% anhydrous citric acid, 0.4% disodium ethylenediaminetetraacetate, and the balance is sodium chloride.
4. The compound amoxicillin powder according to claim 1, characterized in that: The added mass ratio of the sodium bicarbonate and anhydrous citric acid is 1:
1.
5. The compound amoxicillin powder according to claim 1, characterized in that: The particle sizes of the anhydrous magnesium sulfate, anhydrous citric acid, sodium bicarbonate and disodium ethylenediaminetetraacetate are all less than 200 μm.
6. The compound amoxicillin powder according to claim 1, characterized in that: The particle size of the sodium chloride is less than or equal to 150 μm.
7. The compound amoxicillin powder according to claim 1, characterized in that: When the compound amoxicillin powder is prepared into a 10 g / L aqueous solution, the pH value is 5.3-5.
5.
8. A production process of the compound amoxicillin powder according to any one of claims 1 to 7, characterized in that: Screen all raw and auxiliary materials, weigh the prescribed amount of raw and auxiliary materials, put them into a mixer, mix them evenly, and package them.
9. The production process of the compound amoxicillin powder according to claim 8, characterized in that: Control the production environment temperature below 25℃ and the humidity below 40%RH.
Citation Information
Cited By
Preparation method and application of stable amoxicillin atomized spray for external use
CN121668160A
